Rutgers Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States
Medical school in New Brunswick, New Jersey
Clinical Academic Building (CAB, 125 Paterson St, New Brunswick, NJ 08901
About Rutgers Robert Wood Johnson Medical School
Rutgers Robert Wood Johnson Medical School is a medical school of Rutgers University. It is one of the two graduate medical schools of Rutgers Biomedical and Health Sciences, together with New Jersey ...
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Rutgers, The State University of New Jersey
31
National Institute of Allergy and Infectious Diseases (NIAID)
14
Edwards Lifesciences
7
Pfizer
6
Target PharmaSolutions, Inc.
5
Vertex Pharmaceuticals Incorporated
5
Bayer
4
Boehringer Ingelheim
4
Novartis Pharmaceuticals
4
Bristol-Myers Squibb
3
Duke University
3
Clinical Trials at Rutgers Robert Wood Johnson Medical School
During the past decade, Rutgers Robert Wood Johnson Medical School conducted 77 clinical trials. In the 10-year time frame, 77 clinical trials started and 53 clinical trials were completed, i.e. on
average, 68.8% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 23 clinical trials were completed. i.e. 104.5%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Randomized Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected Children
1996-09-01
Completed
819
A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals
1996-02-01
Completed
100
A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)
1996-09-01
Completed
1,292
A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children
2001-11-01
Completed
690
A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents With Advanced HIV Disease
1998-11-01
Completed
390
A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies
2001-05-01
Completed
2,009
A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants
2005-09-01
Completed
2,400
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Rutgers Robert Wood Johnson Medical School" #1 sponsor was "Rutgers, The State University of New Jersey" with 31 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 14 trials
sponsored, "Edwards Lifesciences" with 7 trials sponsored, "Pfizer" with 6 trials sponsored and "Target PharmaSolutions, Inc."
with 6 trials sponsored. Other sponsors include 113 different institutions and
companies that sponsored additional 90 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Rutgers Robert Wood Johnson Medical School"
#1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 8 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 7 trials as a collaborator, "Cystic Fibrosis Foundation" with 6 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 6 trials as a collaborator and "National Institute on Drug Abuse (NIDA)" with 5 trials as a collaborator. Other collaborators include 144 different institutions and companies that were
collaborators in the rest 128 trials.
Clinical Trials Conditions at Rutgers Robert Wood Johnson Medical School
According to Clinical.Site data, the most researched conditions in "Rutgers Robert Wood Johnson Medical School" are
"HIV Infections" (16 trials), "Cystic Fibrosis" (12 trials), "Parkinson's Disease" (7 trials), "Hypertension" (5 trials) and "Depression" (4 trials). Many other conditions were trialed in "Rutgers Robert Wood Johnson Medical School" in a lesser frequency.
Clinical Trials Intervention Types at Rutgers Robert Wood Johnson Medical School
Most popular intervention types in "Rutgers Robert Wood Johnson Medical School" are "Drug" (100 trials), "Other" (25 trials), "Behavioral" (22 trials), "Device" (19 trials) and "Biological" (13 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (34 trials), "Nevirapine" (6 trials), "Zidovudine" (6 trials), "Didanosine" (5 trials) and "IVA" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Rutgers Robert Wood Johnson Medical School
The vast majority of trials in "Rutgers Robert Wood Johnson Medical School" are
161 trials for "All" genders, 18 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at Rutgers Robert Wood Johnson Medical School
Currently, there are NaN active trials in "Rutgers Robert Wood Johnson Medical School".
undefined are not yet recruiting,
22 are recruiting,
12 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 123 completed trials in Rutgers Robert Wood Johnson Medical School,
undefined suspended trials,
and 18 terminated clinical trials to date.
Out of the total trials that were conducted in Rutgers Robert Wood Johnson Medical School, 17 "Phase 1"
clinical trials were conducted, 30 "Phase 2" clinical
trials and 53 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 15 trials, and there were
also 41 trials that are defined as “Not Applicable".